NCT04049396View on ClinicalTrials.gov

Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

March 25, 2019

Study Completion Date

June 15, 2019

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
OTHER

Berberine

24 Patient consumed 6,25 g/day Berberine for 6 weeks

Trial Locations (1)

1477893855

Sciences & Research Branch,Azad University of Tehran, Tehran

All Listed Sponsors
lead

Lida Nejati

OTHER

NCT04049396 - Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD) | Biotech Hunter | Biotech Hunter